Abstract Background and Aims Acute severe autoimmune hepatitis (AS‐AIH) is an evolving
concept and the outcomes and optimal treatment have been less studied. In this study, we …

Background & Aims No standardised definition exists for acute, severe AIH (AS-AIH).
However, rapid identification of AS-AIH and early corticosteroid therapy may prevent the …

Summary Background and Aims To assess whether corticosteroids improve prognosis in
patients with AS‐AIH, and to identify factors at therapy initiation and during therapy …

Background and aim Acute severe autoimmune hepatitis (AS-AIH) is a rare cause of acute
liver failure (ALF), which is often neglected and delayed in treatment. The purpose of this …

Aims The definition of original acute severe autoimmune hepatitis (AS‐AIH) is unclear.
However, its rapid recognition and early treatment is potentially life‐saving. Therefore, we …

Background: Severe acute presentation is an uncommon manifestation of AIH, and it
remains poorly characterized. Materials and Methods: We included 101 patients with AIH …

We read with interest the review by Rahim et al.,(1) in which they gave an elegant summary
of the role, predictors, and optimal timing of corticosteroids and liver transplantation (LT) in …

Autoimmune hepatitis is associated with varied clinical presentations and natural history, as
well as somewhat unpredictable treatment responses. Understanding how to stratify patients …

We thank Dr. de Martin and colleagues for their interest in our paper ''Acute-severe
autoimmune hepatitis (AS-AIH): The role of corticosteroids in improving outcome''. We …

Acute severe presentations of autoimmune hepatitis (AIH) represent a challenge for the
transplant community. As a disease, it is poorly characterized, and there is a weak evidence …